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Background: This report describes a recurrent orbital glomus tumor in an Asian patient.
Case presentation: A healthy 50-year-old Korean man had progressive right exophthalmos and a soft mass on his
right lower lid for 6 months. We evaluated the mass using CT and MRI, and performed excisional biopsy and
pathologic examination. Pathologically, the mass was a glomus tumor. Although proptosis of the right eye
decreased, one month after surgery it increased to almost the same level as before surgery.
Conclusions: This is the first report of an Asian patient with an orbital glomus tumor that demonstrated rapid
re-growth after incision without pain or visual problems.
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Glomus tumors are rare, benign neoplasms of the glo-
mus body, a specialized thermoregulatory arteriovenous
structure. These tumors most commonly present in the
dermis of the digits and palms, [1] and rarely in the
orbit. We describe the unique features of a large orbital
glomus tumor that developed and re-grew rapidly in an
Asian patient.Case presentation
Written informed consent was obtained from the patient
for the publication of this case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal. A healthy
50-year-old Korean man presented with progressive right
exophthalmos and a soft mass on his right lower lid that
had persisted for 6 months (Figure 1A). He had neither
pain nor visual symptoms. On examination, his visual acu-
ity was 20/20 OU. Pupillary, funduscopic, tonometric, and
ocular movements were normal. There was 6 mm of right
proptosis (Hertel). Although mild chemosis was found on
the right eye, no specific pathologic signs were found. On
computed tomography (CT), a well-enhanced mass with
dimensions of 38x31x26 mm was noted in the right intra-
and extra-conal spaces. The mass appeared to be solid
with homogeneous consistency. No bone destruction was* Correspondence: mdjacob@hanmail.net
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reproduction in any medium, provided the orevident on the CT scan. A magnetic resonance image
(MRI) collected for further evaluation showed a large,
lobulated, smooth-margined mass in the lower lateral as-
pect of the right orbit, measuring 28x33x32mm in volume.
The largest portion of the mass was located intraconally
and focally protruded extraconally in the infero-lateral sec-
tion. The mass showed a slightly low signal on T1-weighted
imaging that was moderately enhanced by contrast study
(Figure 1B). The right optic nerve was elevated due to mass
effect, and 3/4 of the optic nerve was enclosed within the
mass. The clinical diagnosis was a cavernous hemangioma
or, less likely, a malignant lymphoma.
To confirm the diagnosis, an incisional biopsy was
performed under local anesthesia. A subciliary incision
exposed the mass to reveal a smooth, round, highly vas-
cularized tumor. After controlling the extensive bleeding
that was encountered, two fragments of the tumor were
obtained. The fragments were irregular and multi-
lobulated reddish masses measuring 0.9x0.7x0.6cm and
0.6x0.5x0.2cm. Pathologically, tumor cells were arranged
in organoid and sheet-like patterns with intimately asso-
ciated, capillary-sized blood vessels. The individual
tumor cells were round, oval, polyhedral, or fusiform.
Nuclei were round or ovoid and centrally placed in pale
or slightly eosinophilic cytoplasm. The cell borders were
not clearly delineated. Tumor cells were intermingled
with thin fascicles of bland spindle cells (Figure 1C) and
showed strong cytoplasmic positivity for smooth muscle
actin (SMA) (Figure 1D). These findings were consistent
with the diagnosis of a glomus tumor. After partial ex-Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Photographs demonstrating right lower lid swelling and proptosis of the right eye (A). T1-weighted magnetic resonance
imaging demonstrated a large, lobulated, smooth-margined mass in the lower lateral aspect of the right orbit, measuring 28x33x32mm in
volume with a low signal that diffusely enhanced with gadolinium (B). Tumor cells were arranged in organoid and sheet-like patterns, and
contained intimately associated capillary-sized blood vessels. Individual tumor cells were round, oval, polyhedral, or fusiform. Nuclei were round
or ovoid and centrally placed in pale or slightly eosinophilic cytoplasm. Cell borders were not clearly delineated. Tumor cells were intermingled
with thin fascicles of bland spindle cells (hematoxylin-eosin, original magnification x400) (C) and showed strong cytoplasmic positivity for smooth
muscle actin (SMA) (immunoperoxidase/hematoxylin counterstain, original magnification x400) (D).
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lower lid swelling visibly reduced (Figure 2A) However,
1 month after surgery, the proptosis increased to 6 mm,Figure 2 Photographs taken the next day of surgery demonstrating d
month after surgery demonstrating recurred right lower lid swelling and p
demonstrated that mass size was increased to that of the initial mass (C).which was almost the same level as before surgery. Lower
lid swelling had also increased (Figure 2B). A follow-up
CT scan indicated that mass size had increased to theecrease proptosis and lid swelling (A). Photographs taken one
roptosis of the right eye (B). Follow-up computerized tomography
Table 1 Characteristics of previously reported orbital glomus tumors
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Interestingly, the patient still had no specific symptoms.
Visual acuity, visual field, and intra-ocular pressure (IOP)
were all within normal ranges. Radiotherapy or debulking
surgery were recommended to address the possibility of
malignancy, but the patient refused any other treatment.
Six months after surgery, the patient was stable. However,
his proptosis had increased to 7 mm.Conclusions
To our knowledge, only 4 other cases of orbital glomus
tumors have been reported, and none of them were in
Asian patients [2-5]. We reviewed these previous reports
and summarized key characteristics to compare to our
case (Table 1). The MRI and gross findings of the tumor
presented here are very similar to those of the case
reported by Pribila et al. [4]. However, the tumor in our
study was histopathologically compatible with a glomus
tumor proper, while the tumor in the previous study
showed both glomus cell tumor and glomangioma char-
acteristics. The previous patient also had pain at presen-
tation, while ours had no pain or vision symptoms.
Unlike in the three previous reports, the tumor in our
patient grew very rapidly. In addition, the tumor showed
rapid re-growth months after surgical debulking. This
fast re-growth may have been an atypical glomus tumor,
which is defined by Folpe et al. as a glomus tumor with
uncertain malignant potential [6]. Fortunately, our pa-
tient had no visual problems, but we recommended con-
tinued close observation and further evaluation to rule
out the possibility of malignancy. To our knowledge, this
is the first report in an Asian patient of an orbital glomus
tumor that demonstrated rapid asymptomatic re-growth
after surgical debulking.
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